在肝细胞癌中基于外体的免疫疗法
Hong Liu1, GuoWei Wang2, ZhaoYi Li3
1Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, 310023, Zhejiang Province, China.
Clinical and experimental medicine
|April 24, 2025
概括
外体细胞对肝细胞癌 (HCC) 通过调节瘤微环境来进行免疫治疗具有前景. 需要进行进一步的研究,以克服外体细胞生成和临床应用方面的挑战,以改善HCC治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 对HCC的全身疗法经常遇到耐药性,限制了临床疗效.
- 外体,纳米级囊泡,正在成为抗瘤免疫力和潜在治疗剂的关键参与者.
研究的目的:
- 在HCC瘤微环境 (TME) 中审查外体的免疫调节功能.
- 阐明外体细胞通过何种机制重塑抑制性HCC TME的机制.
- 为优化HCC的基于外体的免疫疗法提供策略.
主要方法:
- 文献综述侧重于外体生物学和HCC免疫疗法.
- 在TME中对外体介导免疫反应的分析.
- 综合目前对治疗应用的外体工程的知识.
主要成果:
- 外基因组在HCC TME中具有显著的免疫调节能力.
- 外体可以被设计来克服抑制TME特征.
- 有证据表明,外体细胞可以增强HCC的抗瘤免疫反应.
结论:
- 外体细胞通过重编程TME为HCCC免疫疗法提供了一个有希望的途径.
- 外体细胞生产的标准化和货物装载对于临床翻译至关重要.
- 解决安全性和有效性挑战对于基于外体细胞的HCC疗法的成功临床应用至关重要.
相关概念视频
01:27Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K